Finance

Beta
Lists
ACHV:NASDAQ
Achieve Life Sciences Inc
$5.04
-4.73%
(-0.25) 1D
Jun 5, 1:51:35 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHV...
Open
$5.23
High
$5.30
Low
$5.00
Mkt. cap
517.40M
Avg. vol.
1.28M
Volume
295.41K
52-wk high
$6.15
52-wk low
$2.00
EPS
-$1.11
Beta
2.27
Shares outstanding
102.66M
No. of employees
28
Open
$5.23
High
$5.30
Low
$5.00
Mkt. cap
517.40M
Avg. vol.
1.28M
Volume
295.41K
52-wk high
$6.15
52-wk low
$2.00
EPS
-$1.11
Beta
2.27
Shares outstanding
102.66M
No. of employees
28
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to ACHV in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACHV in the last 3 months.
Highest
Current $5.04
$20.00 (+296.83%)
Average
$13.20 (+161.90%)
Lowest
$10.00 (+98.41%)
News stories
From sources across the web
About Achieve Life Sciences Inc
CEO-
Employees28
Founded1991
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.71M
5.32M
3.87M
3.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.86M
9.37M
10.86M
7.17M
Operating expense
12.56M
14.69M
14.73M
10.46M
Total operating expenses
12.56M
14.69M
14.73M
10.46M
Operating income
-12.56M
-14.69M
-14.73M
-10.46M
Other non operating income
-59.00K
-5.00K
7.00K
-13.00K
EBT including unusual items
-12.72M
-14.44M
-14.66M
-10.17M
EBT excluding unusual items
-12.62M
-14.34M
-14.55M
-10.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.72M
-14.44M
-14.66M
-10.17M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.28
-0.28
-0.19
Interest and investment income
192.00K
554.00K
427.00K
297.00K
Interest expense
-191.00K
-192.00K
-251.00K
-274.00K
Net interest expenses
1.00K
362.00K
176.00K
23.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.51M
-14.64M
-14.67M
-10.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more